WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Editas Medicine revenue was $38.69M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $2.8M, down 88.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EDIT annual revenue was $40.5M, with 25.4% growth year-over-year.

EDIT past revenue growth

How has EDIT's revenue growth performed historically?

Company
7.97%
Industry
516.79%
Market
41.36%
EDIT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
EDIT's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
EDIT's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

EDIT revenue history

Current Revenue
$38.7M
Current Earnings
-$109.0M
Current Profit Margin
-281.6%

Be the first to know when EDIT announces revenue.

EDIT Revenue History By Year

EDIT Yearly RevenueEDIT RevenueEDIT ChangeEDIT Revenue Growth
2025-12-31$40.52M$8.21M+25.39%
2024-12-31$32.31M-$45.81M-58.64%
2023-12-31$78.12M$58.41M+296.32%
2022-12-31$19.71M-$5.83M-22.83%
2021-12-31$25.54M-$65.19M-71.85%
2020-12-31$90.73M$70.20M+341.93%
2019-12-31$20.53M-$11.41M-35.71%
2018-12-31$31.94M$18.21M+132.64%
2017-12-31$13.73M$7.68M+126.80%
2016-12-31$6.05M$4.42M+271.58%
2015-12-31$1.63MN/AN/A
2014-12-31$0.00N/AN/A

1 of 1

Editas Medicine Revenue FAQ

What was EDIT's revenue last quarter?

On Invalid Date, Editas Medicine (NASDAQ: EDIT) reported Q1 2026 revenue of $2.83 million up 39.22% year over year. In the same quarter last year, Editas Medicine's revenue was $4.66 million.

What was Editas Medicine's revenue in 2025?

Editas Medicine's annual revenue for the twelve months ending Dec 31, 2025 was $40.52 million, a 25.39% increase year over year.

How much does Editas Medicine make in a day?

Based on Editas Medicine annual revenue for the past five years, EDIT makes an average of $107,513.97 per day.

What was Editas Medicine's annual revenue growth in the past year?

As of Q2 2026, Editas Medicine's revenue has grown 7.97% year over year. This is 508.82 percentage points lower than the US Biotechnology industry revenue growth rate of 516.79%. Editas Medicine's revenue in the past year totaled $38.69 million.

How much does Editas Medicine make in a year?

Editas Medicine's revenue by year for the past five years is:
  • Editas Medicine's revenue for the twelve months ending Dec 31, 2025 was $40.52 million, a 25.39% increase year over year.
  • Editas Medicine's annual revenue for Dec 31, 2024 was $32.31 million, a 58.64% decrease from 2023.
  • Editas Medicine's annual revenue for 2023 was $78.12 million, a 296.32% increase from 2022.
  • Editas Medicine's annual revenue for 2022 was $19.71 million, a 22.83% decrease from 2021.
  • Editas Medicine's annual revenue for 2021 was $25.54 million, a 71.85% decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.